Literature DB >> 4085693

Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy.

H H Parving, J Kastrup, U M Smidt.   

Abstract

The effect of acute arterial blood pressure lowering upon albumin extravasation was studied in 10 patients with nephropathy and retinopathy due to long-standing Type 1 (insulin-dependent) diabetes. The following variables were measured: transcapillary escape rate of albumin (initial disappearance of intravenously injected 125I-labelled human serum albumin), and urinary albumin excretion rate (radial immunodiffusion). The study was performed twice within 2 weeks, with the patients receiving an intravenous injection of either clonidine (225 micrograms) or saline (0.154 mmol/l). The clonidine injection induced the following changes: arterial blood pressure decreased from 134/87 to 107/73 mmHg (p less than 0.01), transcapillary escape rate of albumin declined from 8.1 to 6.7% of the intravascular mass of albumin/h (p less than 0.01), albuminuria diminished from 1434 to 815 micrograms/min (p less than 0.01), and plasma volume raised slightly from 2916 to 2995 ml (p less than 0.05). Our findings demonstrate that the enhanced albumin passage through the wall of the microvasculature characteristically found in long-term Type 1 diabetic patients with clinical microangiopathy is pressure-dependent to a large extent. This may be due to elevated hydrostatic pressure in the microcirculation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085693     DOI: 10.1007/BF00291067

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

2.  Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjects.

Authors:  H H Parving; N Rossing
Journal:  Scand J Clin Lab Invest       Date:  1973-11       Impact factor: 1.713

3.  Transcapillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics.

Authors:  H H P ARVING; S M Rasmussen
Journal:  Scand J Clin Lab Invest       Date:  1973-08       Impact factor: 1.713

Review 4.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

Review 5.  The development, enhancement, and reversal of the secondary complications of diabetes mellitus.

Authors:  M W Steffes; D M Brown; S M Mauer
Journal:  Hum Pathol       Date:  1979-05       Impact factor: 3.466

6.  Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane.

Authors:  M P Cohen; M L Surma
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

7.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

8.  Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice.

Authors:  D H Rohrbach; C W Wagner; V L Star; G R Martin; K S Brown; J W Yoon
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

9.  Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.

Authors:  B J Carrie; B D Myers
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

10.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.

Authors:  G C Viberti; R W Bilous; D Mackintosh; J J Bending; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.